Numeta Ped G16% E, Infusionslösung zur totalen parenteralen Ernährung
7680614250010
CH-61425
Infusionslösung zur totalen parenteralen Ernährung
Associated product:
NUMETA PED G16% E sol perf 6 sach 500 ml
1 / 3
google
Article details
- Package size
- 6 x 500
- Selling units
- 6
- Measure
- ml
- Galenic form
- Infusionslösung zur totalen parenteralen Ernährung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
I
|
77.5 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | WIZUS |
|
III
|
15.5 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
1.03 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.08 G | Substance | Wirkstoff (Principe actif) |
|
II
|
774.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
243.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
1.29 G | Substance | Wirkstoff (Principe actif) |
|
II
|
514.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
488.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
862.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
1.29 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.42 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
309.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
320.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
541.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
387.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
514.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
77.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
477.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
259.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
99.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
979.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
303.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
1.12 G | Substance | Wirkstoff (Principe actif) |
|
II
|
455.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
332.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
979.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
5.2 GL | Substance | Wirkstoff (Principe actif) |
|
12C
|
34.0 GL | Substance | Wirkstoff (Principe actif) |
|
12C
|
206.0 GL | Substance | Wirkstoff (Principe actif) |
|
12C
|
31.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
30.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
4.1 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
8.2 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
8.5 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
39.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
11.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
37.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
3.9 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
26.0 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
155.0 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
31.0 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
24.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
23.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
3.1 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
6.2 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
8.7 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
29.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
9.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
28.0 MMOLL | Substance | Wirkstoff (Principe actif) |
Reimbursement information
Public price
CHF 659.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2023
Authorization holder
Baxter AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 61425
- Drug name
- Numeta Ped, Infusionslösung zur totalen parenteralen Ernährung
- Galenic form
- EMUP
- ATC Code
- B05BA10
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 18/01/2012
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.01.2.
- Domain
- Human medicine
Package details
- Description (FR)
- NUMETA PED G16% E sol perf 6 sach 500 ml
- Description (DE)
- NUMETA PED G16% E Inf Lös 6 Btl 500 ml
- Market launch
- 18/01/2012
- Narcotic (BTM)
- No
Other package sizes (1)
NUMETA PED G19% E sol perf 6 x 1000 ml
6 x 1000 ML
GTIN: 7680614250027